However, these findings are consistent with data from Micallef et al. who showed MARCKS protein upregulation in a small group of BTZ-resistant MM patients [125] and Yang et al. who identified MARCKS upregulation as a resistance marker in primary MM samples [126]. The gene discussed is MARCKS; the disease is Miyoshi myopathy.